Connecticut 2022 2022 Regular Session

Connecticut Senate Bill SB00355 Introduced / Fiscal Note

Filed 05/04/2022

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
SB-355 
AN ACT ESTABLISHING THE 340B DRUG PRICING 
NONDISCRIMINATION ACT. 
AMENDMENT 
LCO No.: 6509 
File Copy No.: 354 
Senate Calendar No.: 252  
 
Primary Analyst: MR 	5/4/22 
Contributing Analyst(s):  	() 
Reviewer: JS 
 
 
 
OFA Fiscal Note 
 
State Impact: 
Agency Affected Fund-Effect FY 23 $ FY 24 $ 
Attorney General 	GF - Revenue 
Gain 
Potential Potential 
UConn Health Ctr. Various - Savings Significant Significant 
Note: Various=Various; GF=General Fund 
  
Municipal Impact: None  
Explanation 
The amendment results in an annual significant savings to the 
University of Connecticut Health Center beginning in FY 23.  The health 
center has multiple 340B covered entities, including John Dempsey 
Hospital, and has not been fully benefiting from the provisions of the 
340B program due to manufacturer and pharmacy benefits manager 
(PBM) practices.  The health center estimates that the foregone savings 
due to these practices has reached approximately $7 million to $9 
million annually.  It is anticipated that the bill will reduce or eliminate 
the practices it prohibits, and consequently result in greater 340B 
savings to UConn Health Center.  
The amendment also specifies that the Office of the Attorney General 
(OAG) has exclusive authority to enforce violations these provisions.  2022SB-00355-R00LCO06509-FNA.DOCX 	Page 2 of 2 
 
 
This may result in a revenue gain to the state, to the extent OAG levies 
fines and penalties under the unfair trade practice provision.   
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely 
for the purposes of information, summarization and explanation and does not represent the intent of the General 
Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of 
informational sources, including the analyst’s professional knowledge. Whenever applicable, agency data is 
consulted as part of the analysis, however final products do not necessarily reflect an assessment from any 
specific department.